Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.
Atrial fibrillation hospitalization
Borderline risk factors
Less-established risk factors
Lone atrial fibrillation
Registry
Substrate
Journal
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
received:
11
10
2019
accepted:
12
12
2019
pubmed:
28
3
2020
medline:
29
6
2021
entrez:
28
3
2020
Statut:
ppublish
Résumé
Data on patient characteristics, prevalence, and outcomes of atrial fibrillation (AF) patients without traditional risk factors, often labelled 'lone AF', are sparse. The RE-LY AF registry included 15 400 individuals who presented to emergency departments with AF in 47 countries. This analysis focused on patients without traditional risk factors, including age ≥60 years, hypertension, coronary artery disease, heart failure, left ventricular hypertrophy, congenital heart disease, pulmonary disease, valve heart disease, hyperthyroidism, and prior cardiac surgery. Patients without traditional risk factors were compared with age- and region-matched controls with traditional risk factors (1:3 fashion). In 796 (5%) patients, no traditional risk factors were present. However, 98% (779/796) had less-established or borderline risk factors, including borderline hypertension (130-140/80-90 mmHg; 47%), chronic kidney disease (eGFR < 60 mL/min; 57%), obesity (body mass index > 30; 19%), diabetes (5%), excessive alcohol intake (>14 units/week; 4%), and smoking (25%). Compared with patients with traditional risk factors (n = 2388), patients without traditional risk factors were more often men (74% vs. 59%, P < 0.001) had paroxysmal AF (55% vs. 37%, P < 0.001) and less AF persistence after 1 year (21% vs. 49%, P < 0.001). Furthermore, 1-year stroke occurrence rate (0.6% vs. 2.0%, P = 0.013) and heart failure hospitalizations (0.9% vs. 12.5%, P < 0.001) were lower. However, risk of AF-related re-hospitalization was similar (18% vs. 21%, P = 0.09). Almost all patients without traditionally defined AF risk factors have less-established or borderline risk factors. These patients have a favourable 1-year prognosis, but risk of AF-related re-hospitalization remains high. Greater emphasis should be placed on recognition and management of less-established or borderline risk factors.
Identifiants
pubmed: 32215649
pii: 5812145
doi: 10.1093/europace/euz360
pmc: PMC7273333
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
870-877Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Références
Nat Rev Cardiol. 2016 Jul 14;13(8):501
pubmed: 27411521
Circulation. 2007 Jun 19;115(24):3050-6
pubmed: 17548732
Europace. 2018 Nov 1;20(11):1750-1757
pubmed: 29518195
Eur Heart J. 2006 Feb;27(3):357-64
pubmed: 16275661
Circulation. 2014 Apr 15;129(15):1568-76
pubmed: 24463370
Eur Heart J. 1999 Jun;20(12):896-9
pubmed: 10329095
J Am Coll Cardiol. 2014 May 6;63(17):1715-23
pubmed: 24530673
Eur Heart J. 2018 Aug 21;39(32):2987-2996
pubmed: 29401239
Europace. 2013 Jan;15(1):18-23
pubmed: 22782972
N Engl J Med. 1987 Sep 10;317(11):669-74
pubmed: 3627174
Eur Heart J. 2016 May 21;37(20):1591-602
pubmed: 26888184
J Interv Card Electrophysiol. 2005 Sep;13(3):203-7
pubmed: 16177847
Heart Lung Circ. 2017 Sep;26(9):990-997
pubmed: 28662919
Europace. 2012 Feb;14(2):184-90
pubmed: 22135317
Am Heart J. 2017 Mar;185:74-84
pubmed: 28267478
Lancet. 2016 Sep 17;388(10050):1161-9
pubmed: 27515684
JAMA. 1985 Dec 27;254(24):3449-53
pubmed: 4068186
Br Heart J. 1954 Apr;16(2):189-94
pubmed: 13160271
Circulation. 2017 Aug 8;136(6):583-596
pubmed: 28784826
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465